Charles River Virtual Seminar

RESAL - Lemanic Animal Facility Network

Friday, December 10, 2021 | 09h00 – 12h00


Registration

This virtual event will be held on Microsoft Teams.

A few days after registering, you’ll receive an Outlook Calendar invitation to join the presentation.


Agenda

9h00           Scientific Reproducibility, Biosecurity And The 3rs – Determining How To Acquire Animal Models

The COVID-19 pandemic and its resulting implications have made research institutions think about how to best manage their animal colonies. For both researchers and facility teams, two common questions have arisen – when does it make sense to breed models in-house, and when is it best to obtain them from a qualified vendor? Find out the answers to these questions in this seminar, where you’ll learn about:

  • Reproducibility, breeding, and genetic integrity
  • Best practices for biosecurity and animal health
  • Generating the right number of animals and the 3Rs
  • Opportunity costs and the best utilization of resources
  • Submitting publications and the ARRIVE Guidelines 2.0

 

10h30          To CRISPR or Not to CRISPR, That Is the Question: IP, Technical Issues & the 3Rs
The use of CRISPR/Cas9* genome editing for the creation of unique rodent models of human disease has revolutionized the field - but every revolution raises challenging issues. View our presentation as we review the latest considerations for the technology as it applies to in vivo research and answer key questions including:

  • CRISPR/Cas9 IP/license constraints: how does it impact your project?
  • Is it compatible with the goals of the 3Rs?
  • Does CRISPR allow for the generation of relevant models?


Speaker
Jean Cozzi, PhD
Innovation Manager, Genetically Engineered Models and Services Europe
Charles River 


Contact

Corinne Schaffner
Business Development Manager
Charles River
P: + 33 6 77 67 03 38
[email protected] 


*CRISPR/CAS9 used under licenses to granted and pending US and international patents from The Broad Institute and ERS Genomics Limited.